Overspending driven by oversized single dose vials of cancer drugs.
Where this comes from
- Record sourced from PubMed, PMID 26932932.
- Also identified by DOI 10.1136/bmj.i788 and PMC identifier 6894487.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
<b>Peter B Bach and colleagues</b> call for an end to contradictory regulatory standards in the US that allow drug manufacturers to boost profits by producing single dose vials containing quantities that increase leftover drug
Medical subject headings
- Antineoplastic Agents
- Cost Control
- Drug Packaging
- Neoplasms